OPEN MARKET SALE AGREEMENTSMOpen Market Sale • November 9th, 2021 • Cue Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2021 Company Industry JurisdictionCue Biopharma, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.001 per share (the “Common Shares”), having an aggregate offering price of up to $80,000,000 on the terms set forth in this agreement (this “Agreement”).
Third Amendment to License AgreementLicense Agreement • November 9th, 2021 • Cue Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 9th, 2021 Company IndustryThis Third Amendment to License Agreement (“Third Amendment”) is made as of October 1, 2021, by and between Cue Biopharma, Inc. (“Licensee”) and MIL 21E, LLC (“Licensor”).